Skip to main content

Table 4 Characteristics of patients with nevi

From: Circulating tumor DNA tracking through driver mutations as a liquid biopsy-based biomarker for uveal melanoma

Code LB

Sex

Age (Y)

Location

ctDNA

FA

B

TN

FU

RX

RF

Notes

06

F

73

Choroid

0

0

3

Flat

81

–

0

–

07

M

72

Choroid

0

0

NA

Flat

53

–

0

–

08

M

80

Choroid

0

0

2

Flat

141

–

0

–

09

M

79

Choroid

0

0

1.5

1.3

170

–

0

–

10

M

83

Choroid

0

0

3

Flat

182

–

0

Bilateral

11

M

64

Choroid

0

0

4

Flat

48

–

0

–

12

F

70

Iris

0

0

2.4

0.6

170

–

0

–

20

M

77

Choroid

3.1

1.1

1.8

NA

11

+

4

OP, S, F, PP

23

F

57

Choroid

12.1

1.8

NA

NA

5

+

4

T, OP, F, S

24

F

68

Choroid

4.3

0.7

NA

2.3

15

–

3

PP, F, T

25

F

35

Choroid

13.3

28

4.5

2.47

13

+

4

F, S, T, G

34

M

80

Choroid

2.3

0.6

NA

NA

9

–

2

OP, F

35

F

60

Choroid

0

0

2

Flat

12

–

0

–

37

F

47

Choroid

1

7

7

OD: Flat.

OS: 1

82

–

0

Bilateral

38

F

45

Choroid

2.3

6

3.2

1.7

12

–

4

OP, F, PP, S

45

F

60

Choroid

4.4

1.8

NA

2.7

18

–

2

PP, T

  1. + = anti-VEGF treatment; B Basal diameter (mm); ctDNA (molecules/ml). F fluid; FA percentage of fractional abundance; FU follow-up time (months); G Growth; OP orange pigment; PP peripapillary; RF number of risk factors; Rx Treatment; S visual symptoms; T thickness > 2 mm; TN thickness (mm);